Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Appelhans Dannielle | Chief Operating Officer | 11 | $0 | $6.9K | 2023-02-24 |
| CAGNONI PABLO J | Director | 18 | $98.7K | $48.1K | 2023-02-01 |
| Turka Laurence A. | Chief Scientific Officer | 13 | $0 | $17.2K | 2023-01-31 |
| Schaffert Susanne | Director | 1 | $0 | $0 | 2022-07-29 |
| Prener Anne | Director | 3 | $0 | $0 | 2022-05-12 |
| Symonds Jonathan | Director | 6 | $575.0K | $0 | 2022-05-12 |
| Holles Natalie C. | Director | 4 | $0 | $0 | 2022-05-12 |
| Sohn Catherine A. | Director | 6 | $57.5K | $0 | 2022-05-12 |
| Cuss Francis M | Director | 6 | $230.0K | $0 | 2022-05-12 |
| Rosenblatt Michael | Director | 5 | $0 | $0 | 2022-05-12 |
| Epstein David R | Director | 13 | $101.1K | $1.87M | 2022-05-12 |
| AFEYAN NOUBAR | Director, 10% Owner | 8 | $6.09M | $0 | 2022-05-12 |
| Keson-Brookes Maiken | CLO & Corp. Secretary | 11 | $0 | $523.9K | 2022-02-01 |
| Carmona Jose | Chief Financial Officer | 3 | $0 | $0 | 2022-01-31 |
| Coughlin Christina M. | Chief Medical Officer | 4 | $104.9K | $0 | 2021-01-29 |
| OH ANDREW M. | Chief Financial Officer | 4 | $0 | $0 | 2020-05-15 |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | 27 | $0 | $2.57M | 2019-12-16 |
| LANGER ROBERT | Director | 14 | $0 | $417.1K | 2019-10-14 |
| NISSEN TORBEN STRAIGHT | President | 8 | $0 | $293.9K | 2019-07-24 |
| Flagship Ventures Fund V, L.P. | 10% Owner | 20 | $0 | $0 | 2018-07-20 |
| Pomerantz Roger | Director | 2 | $2.3K | $0 | 2018-07-20 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Appelhans Dannielle | CEO and President | S Sale | 2023-02-24 | 2023-02-27 | 10,385 | $0.13 | $1.4K | 0 | SEC↗ |
| Appelhans Dannielle | CEO and President | S Sale | 2023-02-01 | 2023-02-01 | 3,878 | $0.25 | $970 | 10,385 | SEC↗ |
| CAGNONI PABLO J | Director | S Sale | 2023-02-01 | 2023-02-01 | 8,448 | $0.25 | $2.1K | 66,082 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise deriv | 2023-01-31 | 2023-01-31 | 8,625 | — | $0 | 25,875 | SEC↗ |
| CAGNONI PABLO J | Director | M Exercise deriv | 2023-01-31 | 2023-01-31 | 25,000 | — | $0 | 75,000 | SEC↗ |
| Appelhans Dannielle | CEO and President | M Exercise deriv | 2023-01-31 | 2023-02-01 | 7,500 | — | $0 | 22,500 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | S Sale | 2023-01-31 | 2023-01-31 | 2,593 | $0.24 | $622 | 18,391 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise | 2023-01-31 | 2023-01-31 | 8,625 | — | $0 | 20,984 | SEC↗ |
| CAGNONI PABLO J | Director | S Sale | 2023-01-31 | 2023-01-31 | 7,240 | $0.24 | $1.7K | 74,530 | SEC↗ |
| CAGNONI PABLO J | Director | M Exercise | 2023-01-31 | 2023-01-31 | 25,000 | — | $0 | 81,770 | SEC↗ |
| Appelhans Dannielle | CEO and President | M Exercise | 2023-01-31 | 2023-02-01 | 7,500 | — | $0 | 14,263 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise deriv | 2023-01-29 | 2023-01-31 | 7,438 | — | $0 | 14,874 | SEC↗ |
| CAGNONI PABLO J | Director | M Exercise deriv | 2023-01-29 | 2023-01-31 | 21,250 | — | $0 | 42,500 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise | 2023-01-29 | 2023-01-31 | 7,438 | — | $0 | 12,359 | SEC↗ |
| CAGNONI PABLO J | Director | M Exercise | 2023-01-29 | 2023-01-31 | 21,250 | — | $0 | 56,770 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | S Sale | 2022-08-10 | 2022-08-12 | 5,737 | $0.80 | $4.6K | 6,763 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | M Exercise deriv | 2022-08-09 | 2022-08-12 | 12,500 | — | $0 | 37,500 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | M Exercise | 2022-08-09 | 2022-08-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Schaffert Susanne | Director | A Award deriv | 2022-07-29 | 2022-08-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 499,762 | — | $0 | 499,762 | SEC↗ |
| Symonds Jonathan | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Cuss Francis M | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Holles Natalie C. | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2022-04-21 | 2022-04-22 | 30,000 | $1.44 | $43.2K | 4,720,012 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | S Sale | 2022-02-01 | 2022-02-01 | 2,517 | $6.57 | $16.5K | 4,921 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | S Sale | 2022-02-01 | 2022-02-01 | 2,732 | $6.57 | $17.9K | 5,343 | SEC↗ |
| CAGNONI PABLO J | CEO and President | S Sale | 2022-02-01 | 2022-02-01 | 6,730 | $6.57 | $44.2K | 35,520 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 143,750 | — | $0 | 143,750 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 34,500 | — | $0 | 34,500 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | A Award deriv | 2022-01-31 | 2022-02-01 | 34,500 | — | $0 | 34,500 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | A Award deriv | 2022-01-31 | 2022-02-01 | 143,750 | — | $0 | 143,750 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Carmona Jose | Chief Financial Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 143,750 | — | $0 | 143,750 | SEC↗ |
| Carmona Jose | Chief Financial Officer | A Award deriv | 2022-01-31 | 2022-02-01 | 34,500 | — | $0 | 34,500 | SEC↗ |
| CAGNONI PABLO J | CEO and President | A Award deriv | 2022-01-31 | 2022-02-01 | 365,000 | — | $0 | 365,000 | SEC↗ |
| CAGNONI PABLO J | CEO and President | A Award deriv | 2022-01-31 | 2022-02-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise deriv | 2022-01-29 | 2022-02-01 | 7,438 | — | $0 | 22,312 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | M Exercise deriv | 2022-01-29 | 2022-02-01 | 8,075 | — | $0 | 24,225 | SEC↗ |
| CAGNONI PABLO J | CEO and President | M Exercise deriv | 2022-01-29 | 2022-02-01 | 21,250 | — | $0 | 63,750 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | M Exercise | 2022-01-29 | 2022-02-01 | 7,438 | — | $0 | 7,438 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | M Exercise | 2022-01-29 | 2022-02-01 | 8,075 | — | $0 | 8,075 | SEC↗ |
| CAGNONI PABLO J | CEO and President | M Exercise | 2022-01-29 | 2022-02-01 | 21,250 | — | $0 | 42,250 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | A Award deriv | 2021-08-31 | 2021-09-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Appelhans Dannielle | Chief Operating Officer | A Award deriv | 2021-08-31 | 2021-09-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Holles Natalie C. | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Cuss Francis M | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Symonds Jonathan | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2021-05-12 | 2021-05-13 | 27,919 | — | $0 | 27,919 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 15,393,593 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 5,859,414 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 2,633,703 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | M Exercise deriv | 2021-03-15 | 2021-03-15 | 25,000 | — | $0 | 225,000 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | M Exercise | 2021-03-15 | 2021-03-15 | 25,000 | $7.70 | $192.5K | 25,000 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | S Sale | 2021-03-15 | 2021-03-15 | 25,000 | $20.24 | $506.0K | 0 | SEC↗ |
| Epstein David R | Director | S Sale | 2021-02-11 | 2021-02-16 | 26,704 | $14.93 | $398.7K | 4,690,012 | SEC↗ |
| Epstein David R | Director | S Sale | 2021-02-10 | 2021-02-10 | 7,404 | $14.79 | $109.5K | 4,716,716 | SEC↗ |
| Epstein David R | Director | S Sale | 2021-02-09 | 2021-02-10 | 2,100 | $14.83 | $31.1K | 4,724,120 | SEC↗ |
| Epstein David R | Director | S Sale | 2021-02-08 | 2021-02-10 | 89,233 | $14.88 | $1.33M | 4,726,220 | SEC↗ |
| CAGNONI PABLO J | CEO and President | A Award deriv | 2021-01-29 | 2021-02-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CAGNONI PABLO J | CEO and President | A Award deriv | 2021-01-29 | 2021-02-02 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | A Award deriv | 2021-01-29 | 2021-02-02 | 131,250 | — | $0 | 131,250 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | A Award deriv | 2021-01-29 | 2021-02-02 | 29,750 | — | $0 | 29,750 | SEC↗ |
| Coughlin Christina M. | Chief Medical Officer | A Award deriv | 2021-01-29 | 2021-02-02 | 142,500 | — | $0 | 142,500 | SEC↗ |
| Coughlin Christina M. | Chief Medical Officer | A Award deriv | 2021-01-29 | 2021-02-02 | 32,300 | — | $0 | 32,300 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | A Award deriv | 2021-01-29 | 2021-02-02 | 32,300 | — | $0 | 32,300 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | A Award deriv | 2021-01-29 | 2021-02-02 | 142,500 | — | $0 | 142,500 | SEC↗ |
| Carmona Jose | Chief Financial Officer | A Award deriv | 2020-11-30 | 2020-12-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 115,771 | — | $0 | 115,771 | SEC↗ |
| Symonds Jonathan | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Cuss Francis M | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Holles Natalie C. | Director | A Award deriv | 2020-05-21 | 2020-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OH ANDREW M. | Chief Financial Officer | M Exercise deriv | 2020-05-15 | 2020-05-19 | 5,000 | — | $0 | 755,500 | SEC↗ |
| OH ANDREW M. | Chief Financial Officer | M Exercise | 2020-05-15 | 2020-05-19 | 5,000 | $4.74 | $23.7K | 5,000 | SEC↗ |
| Coughlin Christina M. | Chief Medical Officer | P Buy | 2020-04-22 | 2020-04-24 | 19,000 | $5.52 | $104.9K | 19,000 | SEC↗ |
| CAGNONI PABLO J | CEO and President | P Buy | 2020-04-14 | 2020-04-15 | 21,000 | $4.70 | $98.7K | 21,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-03-17 | 2020-03-19 | 5,000 | $3.76 | $18.8K | 4,815,453 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-03-13 | 2020-03-17 | 5,000 | $3.82 | $19.1K | 4,805,453 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-03-13 | 2020-03-17 | 5,000 | $4.00 | $20.0K | 4,810,453 | SEC↗ |
| OH ANDREW M. | Chief Financial Officer | A Award deriv | 2020-01-31 | 2020-02-03 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Turka Laurence A. | Chief Scientific Officer | A Award deriv | 2020-01-31 | 2020-02-03 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CAGNONI PABLO J | Chief Executive Officer | A Award deriv | 2020-01-31 | 2020-02-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Coughlin Christina M. | Chief Medical Officer | A Award deriv | 2020-01-31 | 2020-02-03 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2019-12-31 | 2020-01-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-12-16 | 2019-12-18 | 48,000 | — | $0 | 523,157 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-12-16 | 2019-12-18 | 48,000 | $2.87 | $137.8K | 82,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-12-16 | 2019-12-18 | 48,000 | $13.48 | $647.0K | 34,843 | SEC↗ |
| Keson-Brookes Maiken | CLO & Corp. Secretary | A Award deriv | 2019-11-29 | 2019-12-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| LANGER ROBERT | Director | M Exercise deriv | 2019-10-14 | 2019-10-17 | 7,500 | — | $0 | 120,000 | SEC↗ |
| LANGER ROBERT | Director | M Exercise | 2019-10-14 | 2019-10-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| LANGER ROBERT | Director | S Sale | 2019-10-14 | 2019-10-17 | 7,500 | $8.52 | $63.9K | 0 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-09-17 | 2019-09-18 | 11,877 | — | $0 | 571,157 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-09-17 | 2019-09-18 | 11,877 | $10.05 | $119.4K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-09-17 | 2019-09-18 | 11,877 | $2.87 | $34.1K | 46,720 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-09-16 | 2019-09-18 | 36,123 | — | $0 | 583,034 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-09-16 | 2019-09-18 | 36,123 | $2.87 | $103.7K | 70,966 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-09-16 | 2019-09-18 | 36,123 | $10.13 | $365.9K | 34,843 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | M Exercise deriv | 2019-07-24 | 2019-07-26 | 175,000 | — | $0 | 175,000 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | M Exercise deriv | 2019-07-24 | 2019-07-26 | 32,146 | — | $0 | 82,854 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | M Exercise | 2019-07-24 | 2019-07-26 | 32,146 | $0.19 | $6.1K | 2,052,450 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | M Exercise | 2019-07-24 | 2019-07-26 | 175,000 | $0.18 | $31.5K | 2,020,304 | SEC↗ |
| LANGER ROBERT | Director | M Exercise deriv | 2019-07-15 | 2019-07-17 | 7,500 | — | $0 | 127,500 | SEC↗ |
| LANGER ROBERT | Director | M Exercise | 2019-07-15 | 2019-07-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| LANGER ROBERT | Director | S Sale | 2019-07-15 | 2019-07-17 | 7,500 | $14.94 | $112.0K | 0 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-06-20 | 2019-06-24 | 243 | — | $0 | 619,157 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-06-20 | 2019-06-24 | 243 | $13.93 | $3.4K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-06-20 | 2019-06-24 | 243 | $2.87 | $697 | 35,086 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-06-19 | 2019-06-19 | 18,399 | — | $0 | 619,400 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-06-19 | 2019-06-19 | 18,399 | $2.87 | $52.8K | 53,242 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-06-19 | 2019-06-19 | 18,399 | $13.80 | $253.9K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-06-18 | 2019-06-19 | 10,858 | — | $0 | 637,799 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-06-18 | 2019-06-19 | 10,858 | $2.87 | $31.2K | 45,701 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-06-18 | 2019-06-19 | 10,858 | $14.27 | $154.9K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-06-17 | 2019-06-19 | 18,500 | — | $0 | 648,657 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-06-17 | 2019-06-19 | 18,500 | $14.10 | $260.9K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-06-17 | 2019-06-19 | 18,500 | $2.87 | $53.1K | 53,343 | SEC↗ |
| Cuss Francis M | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 39,094 | — | $0 | 39,094 | SEC↗ |
| LANGER ROBERT | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Symonds Jonathan | Director | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2019-05-23 | 2019-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LANGER ROBERT | Director | M Exercise deriv | 2019-04-15 | 2019-04-17 | 7,500 | — | $0 | 135,000 | SEC↗ |
| LANGER ROBERT | Director | S Sale | 2019-04-15 | 2019-04-17 | 7,500 | $17.57 | $131.8K | 0 | SEC↗ |
| LANGER ROBERT | Director | M Exercise | 2019-04-15 | 2019-04-17 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | S Sale | 2019-04-08 | 2019-04-10 | 2,100 | $20.00 | $42.0K | 1,845,304 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | S Sale | 2019-04-05 | 2019-04-05 | 12,096 | $20.00 | $241.9K | 1,847,404 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | S Sale | 2019-04-03 | 2019-04-05 | 500 | $20.00 | $10.0K | 1,859,500 | SEC↗ |
| Holles Natalie C. | Director | A Award deriv | 2019-03-29 | 2019-04-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-03-15 | 2019-03-19 | 48,000 | — | $0 | 667,157 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | S Sale | 2019-03-15 | 2019-03-19 | 48,000 | $15.84 | $760.3K | 34,843 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-03-15 | 2019-03-19 | 48,000 | $2.87 | $137.8K | 82,843 | SEC↗ |
| CAGNONI PABLO J | Chief Executive Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NISSEN TORBEN STRAIGHT | President | A Award deriv | 2019-01-31 | 2019-02-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OH ANDREW M. | Chief Financial Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise deriv | 2019-01-22 | 2019-01-24 | 34,843 | — | $0 | 715,157 | SEC↗ |
| CARPENTER CHRISTOPHER L. | Chief Medical Officer | M Exercise | 2019-01-22 | 2019-01-24 | 34,843 | $2.87 | $100.0K | 34,843 | SEC↗ |
| LANGER ROBERT | Director | M Exercise deriv | 2019-01-14 | 2019-01-18 | 7,500 | — | $0 | 142,500 | SEC↗ |
| LANGER ROBERT | Director | M Exercise | 2019-01-14 | 2019-01-18 | 7,500 | $0.15 | $1.1K | 7,500 | SEC↗ |
| LANGER ROBERT | Director | S Sale | 2019-01-14 | 2019-01-18 | 7,500 | $14.59 | $109.4K | 0 | SEC↗ |
| CAGNONI PABLO J | Chief Executive Officer | A Award deriv | 2018-10-31 | 2018-11-01 | 164,400 | — | $0 | 164,400 | SEC↗ |
| CAGNONI PABLO J | Chief Executive Officer | A Award deriv | 2018-10-31 | 2018-11-01 | 193,400 | — | $0 | 193,400 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| Symonds Jonathan | Director | P Buy | 2018-07-20 | 2018-07-23 | 25,000 | $23.00 | $575.0K | 25,000 | SEC↗ |
| Cuss Francis M | Director | P Buy | 2018-07-20 | 2018-07-23 | 10,000 | $23.00 | $230.0K | 10,000 | SEC↗ |
| Pomerantz Roger | Director | P Buy | 2018-07-20 | 2018-07-23 | 100 | $23.00 | $2.3K | 100 | SEC↗ |
| Sohn Catherine A. | Director | P Buy | 2018-07-20 | 2018-07-23 | 2,500 | $23.00 | $57.5K | 2,500 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 3,830,402 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 15,323,593 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 2,563,703 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 1,781,843 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| Flagship Ventures Fund V, L.P. | 10% Owner | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| Symonds Jonathan | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Cuss Francis M | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 1,902,977 | — | $0 | 1,902,977 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LANGER ROBERT | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Pomerantz Roger | Director | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AFEYAN NOUBAR | Director, 10% Owner | A Award deriv | 2018-07-17 | 2018-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |